Navigation Links
Researchers find possible target to treat deadly bloodstream infections
Date:2/28/2008

Researchers at the University of Illinois at Chicago have discovered a possible target to treat bloodstream bacterial infections.

Most bacterial pathogens can invade the bloodstream, which can lead to severe sepsis, a syndrome that kills about 215,000 of the 750,000 people affected in the United States each year, according to a study published in the journal Critical Care Medicine.

"The growth of bacterial pathogens in blood represents one of the most dangerous stages of infection," said Alexander Mankin, professor and associate director of UIC's Center for Pharmaceutical Biotechnology. "Before we can discover an antibiotic to treat bloodstream infections, we first had to discover which enzymes are essential for bacteria to live in the bloodstream.

"Our major goal was to identify genes that are critical for the survival and growth of bacteria in blood."

The study appears in the February issue of the journal PLoS Pathogens.

A graduate student in Mankin's laboratory, Shalaka Samant, infected human blood in a test tube with E. coli bacteria, a major cause of bloodstream infections in hospitalized patients.

Using a novel technique developed in Mankin's laboratory, Samant discovered that 19 E. coli mutants out of more than 4,000 she tested could not grow in blood. The majority of the mutants carried a deletion of a gene involved in making nucleotides, the building blocks of DNA and RNA.

The result suggested that the biosynthesis nucleotides is crucial for the growth of the bacteria in human blood, Samant said.

Samant expanded her research to another bloodstream pathogen -- Bacillus anthracis, the causative agent of anthrax.

"There are few treatment options available for the late stages of anthrax infections," Samant said. "We found that, similar to E. coli, anthracis bacilli that could not biosynthesize nucleotides also were unable to grow in blood."

To add to Samant's study, a team of researchers led by Dr. James Cook, chief of infectious diseases, immunology and internal medicine at the University of Illinois Medical Center at Chicago, showed Bacillus anthracis mutants that were unable to synthesize nucleotides were not able to infect mice. After they were infected with anthrax, the mice remained healthy, with no bacteria detected in their blood.

Mankin said the enzymes of nucleotide biosynthesis could make excellent antibiotic targets. The UIC Center for Pharmaceutical Biotechnology is now working to identify drugs that inhibit these enzymes.


'/>"/>

Contact: Sam Hostettler
samhos@uic.edu
312-355-2522
University of Illinois at Chicago
Source:Eurekalert

Related medicine news :

1. Rutgers researchers unlock mysteries of vitamin A metabolism during embryonic development
2. U of Minn researchers discover genetic cancer link between humans and dogs
3. New genetic association with schizophrenia found by researchers
4. Thomson Scientific To Honor Australias Top Researchers With Dedicated Australian Research Day
5. This is your brain on jazz: researchers use MRI to study spontaneity, creativity
6. First look: Princeton researchers peek into deepest recesses of human brain
7. U of Minn researchers find primary alcohol prevention programs are needed for tweens
8. Researchers collaborate to find new vaccine technology decreases E. coli in beef cattle
9. Researchers identify and shut down protein that fuels ovarian cancer
10. Implementers, Advocates, Researchers Call on Congress to Honor Lantos Commitment to Public Health and Human Rights by Placing Evidence over Ideology
11. Penn researchers engineer first system of human nerve-cell tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Planet Fitness, ... the U.S., announced today its plans to open a flagship location in Covington, LA ... the former Rooms To Go store next to Office Depot in the Holiday Square ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
(Date:10/4/2017)... Oct. 4, 2017  South Korean-based healthcare product Development ... aide "cprCUBE" on Kickstarter. The device will educate the ... arrests with better efficiency compared to the dated and ... feedback on efficacy of the compression for a more ... a goal to raise $5,000. ...
(Date:10/2/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... , and named its founder as Diplomat,s chief information ... Tennessee , will operate under Diplomat subsidiary Envoy ... for health care partners to include IT outsourcing, consulting, ... "In an interoperable world, technology delivers comprehensive insight and ...
Breaking Medicine Technology: